相似文献
1
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization.
J Infect Dis. 2011 Jun 1;203(11):1542-5. doi: 10.1093/infdis/jir139.
2
Diagnostic Usefulness of Varicella-Zoster Virus Real-Time Polymerase Chain Reaction Analysis of DNA in Saliva and Plasma Specimens From Patients With Herpes Zoster.
J Infect Dis. 2017 Dec 27;217(1):51-57. doi: 10.1093/infdis/jix508.
3
Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine.
Clin Infect Dis. 2014 Apr;58(8):1125-8. doi: 10.1093/cid/ciu058. Epub 2014 Jan 26.
4
Varicella-zoster virus in the saliva of patients with herpes zoster.
J Infect Dis. 2008 Mar 1;197(5):654-7. doi: 10.1086/527420.
5
Use of Saliva to Identify Varicella Zoster Virus Infection of the Gut.
Clin Infect Dis. 2015 Aug 15;61(4):536-44. doi: 10.1093/cid/civ320. Epub 2015 Apr 16.
6
Varicella-zoster virus DNA level and facial paralysis in Ramsay Hunt syndrome.
Ann Otol Rhinol Laryngol. 2004 Sep;113(9):700-5. doi: 10.1177/000348940411300905.
7
Varicella zoster virus in Bell's palsy: a prospective study.
Braz J Otorhinolaryngol. 2010 May-Jun;76(3):370-3. doi: 10.1590/S1808-86942010000300016.
8
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.
J Med Virol. 2008 Jun;80(6):1116-22. doi: 10.1002/jmv.21173.
9
Sampling of herpes zoster skin lesion types and the impact on viral DNA detection.
J Virol Methods. 2013 Mar;188(1-2):145-7. doi: 10.1016/j.jviromet.2012.12.013. Epub 2012 Dec 27.
10
[Detection of varicella-zoster virus DNA in tear fluid and saliva of patients with Ramsay Hunt syndrome].
Nihon Jibiinkoka Gakkai Kaiho. 2000 Aug;103(8):928-36. doi: 10.3950/jibiinkoka.103.928.
引用本文的文献
1
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine.
Biomolecules. 2024 Jun 22;14(7):739. doi: 10.3390/biom14070739.
2
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.
Lancet Reg Health West Pac. 2023 Feb 18;34:100707. doi: 10.1016/j.lanwpc.2023.100707. eCollection 2023 May.
3
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.
J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.
4
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.
J Infect Dis. 2018 Mar 13;217(7):1055-1059. doi: 10.1093/infdis/jix653.
5
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial.
Arthritis Rheumatol. 2017 Oct;69(10):1969-1977. doi: 10.1002/art.40187. Epub 2017 Sep 6.
6
The emerging safety profile of JAK inhibitors in rheumatic disease.
Nat Rev Rheumatol. 2017 Apr;13(4):234-243. doi: 10.1038/nrrheum.2017.23. Epub 2017 Mar 2.
7
One-year follow-up of patients with long-lasting post-herpetic neuralgia.
BMC Infect Dis. 2014 Nov 1;14:556. doi: 10.1186/s12879-014-0556-6.
8
Varicella-zoster.
Handb Clin Neurol. 2014;123:265-83. doi: 10.1016/B978-0-444-53488-0.00012-2.
9
Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years.
J Med Virol. 2014 Feb;86(2):360-2. doi: 10.1002/jmv.23834. Epub 2013 Nov 6.
10
Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.
J Med Virol. 2013 Sep;85(9):1669-77. doi: 10.1002/jmv.23634. Epub 2013 Jun 18.
本文引用的文献
1
Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
Curr Top Microbiol Immunol. 2010;342:189-209. doi: 10.1007/82_2010_29.
2
Neurological disease produced by varicella zoster virus reactivation without rash.
Curr Top Microbiol Immunol. 2010;342:243-53. doi: 10.1007/82_2009_3.
3
Viremia in acute herpes zoster.
J Infect Dis. 2009 Jul 1;200(1):26-32. doi: 10.1086/599381.
4
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.
5
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.
J Med Virol. 2008 Jun;80(6):1116-22. doi: 10.1002/jmv.21173.
6
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.
J Infect Dis. 2008 Mar 1;197 Suppl 2:S170-7. doi: 10.1086/522161.
7
Varicella-zoster virus in the saliva of patients with herpes zoster.
J Infect Dis. 2008 Mar 1;197(5):654-7. doi: 10.1086/527420.
8
Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.
J Infect Dis. 2008 Mar 1;197(5):646-53. doi: 10.1086/527419.
9
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.
J Infect Dis. 2007 Feb 15;195(4):502-10. doi: 10.1086/510532. Epub 2007 Jan 10.
10
Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual.
Clin Infect Dis. 2006 Nov 15;43(10):1301-3. doi: 10.1086/508539. Epub 2006 Oct 11.
Zotero 插件